Table of Contents
- 01Introduction
- 02What the Qualified Person Role Actually Is
- 03What a QP Reviews Before Certifying a Batch
- 04Becoming a QP: Eligibility and Training
- 05A Day, or a Week, in the Life
- 06Why Companies Struggle to Find Enough QPs
- 07How QP Work Differs From US-Style Quality Roles
- 08What Draws People Toward QP Work
- 09Conclusion
Introduction
In most of the world's pharmaceutical quality systems, a batch release decision is a committee outcome: the quality unit reviews the record, signs off, and the batch ships. In the European Union, the law requires something more specific. A single named individual, the Qualified Person, personally certifies that a batch was manufactured and tested in accordance with Good Manufacturing Practice and the marketing authorization before it can be released. That individual is legally accountable for the decision, by name, under European medicines law, in a way that does not disappear into the company's broader quality organization even when the certification itself is routine. It is one of the few roles left in life sciences regulation where the job title itself carries direct legal liability, and understanding what it actually involves explains why companies struggle to keep enough of them on staff.
What the Qualified Person Role Actually Is
The Qualified Person, often shortened to QP, is defined in EU pharmaceutical legislation, principally Directive 2001/83/EC for human medicines and its companion directive for veterinary products, with the detailed duties set out in Annex 16 of the EU GMP guidelines. A QP must be formally named to a manufacturing or importation authorization and registered with the relevant national competent authority before they can certify a single batch. This is not an internal job title a company can assign on its own; it is a regulatory designation the authority has to recognize. Once named, the QP is personally responsible for certifying that each batch complies with its marketing authorization, GMP, and any additional national requirements, and that responsibility does not transfer to the company or dilute across a committee. If something goes wrong with a released batch, the QP who certified it is the one whose decision gets examined first.
88 open now
Quality operations roles
Senior Quality Assurance Specialist, OperationsWave Life Sciences USALexington, MA$129K
Quality Assurance SupervisorPadagisMinneapolis, MN$67K–$87K
Sr. Site Quality Authority (SQA), Investigations & CompliancePfizerMcPherson, KS$99K–$165K
Senior Specialist, Quality Assurance (Nights)Cardinal HealthEast Lansing, MI$69K–$88K
What a QP Reviews Before Certifying a Batch
Certification is the final step of a much longer review, and a QP is expected to have genuine oversight of what sits behind it rather than a rubber stamp. That typically includes the completed batch manufacturing and packaging records, confirmation that any deviations recorded during manufacture were investigated and closed with an adequate justification, environmental monitoring and in-process testing results, the status of any related change controls, and the qualification status of the starting materials and active substance supplier. For products with more complex supply chains, a QP also has to be satisfied that imported intermediates or active substances were manufactured to an equivalent GMP standard, which for cell and gene therapy products with short shelf lives and global component sourcing can mean compressing that entire review into a matter of hours.
Becoming a QP: Eligibility and Training
The eligibility bar is set in the directive itself, not left to employer discretion. A prospective QP generally needs a relevant scientific degree, such as pharmacy, chemistry, or a related life science, followed by several years of practical experience in a manufacturing environment performing qualitative and quantitative analysis and the kinds of quality checks GMP requires. The exact combination of academic qualification and practical experience varies somewhat by EU member state, and some national schemes, including those run by professional pharmacy and chemistry bodies, offer a formal QP qualification route that combines coursework with assessed industrial experience. The United Kingdom, post-Brexit, operates its own largely parallel Responsible Person scheme with similar intent, which means a QP qualified under one system is not automatically recognized under the other, something that trips up candidates who assume the credentials travel freely across borders.
A Day, or a Week, in the Life
Much of a QP's working time is spent reviewing batch documentation in a queue that rarely empties, and the job is as much about managing dependencies as it is about reading records. A batch cannot be certified until every linked deviation is closed and every relevant change control has reached an approved state, so a QP often spends more time chasing down an outstanding investigation than actually reviewing the finished paperwork. Larger manufacturers with multiple sites frequently operate a network of QPs who can certify across different product lines or locations, and at contract manufacturers it is common for a single QP to be responsible for batches made on behalf of several different sponsor companies, each with its own specification and marketing authorization to track.
The job also carries a weight that is hard to see from outside it. A QP does not get to delegate the final call or split the decision with a colleague, and that can make the role a poor fit for someone who wants quality authority without sole accountability. Experienced QPs often describe the job as equal parts technical review and risk judgment, since no batch record is ever perfectly clean; the real skill is distinguishing a deviation that was genuinely investigated and resolved from one where the paperwork merely looks complete. Some QPs build informal networks with peers at other companies, sharing anonymized discussion of tricky certification decisions, precisely because the role offers so little built-in second opinion within their own organization.
Why Companies Struggle to Find Enough QPs
The supply of qualified, experienced QPs has not kept pace with demand, particularly in biologics and cell and gene therapy manufacturing, where batch volumes are growing fastest and the review work per batch is often more complex than for a conventional small-molecule product. The eligibility requirements themselves limit the pipeline, since becoming a QP takes years of hands-on manufacturing experience before someone is even eligible to be named, and that experience is harder to accumulate quickly in newer modalities that did not exist a decade ago. Some companies address the gap by sharing QP capacity across sites or contracting with consultancies that provide QP services, but for manufacturers expanding capacity, the lead time to get a new QP named and registered is a real constraint on how fast they can scale output, not just a hiring inconvenience.
This shortage has started to shape where manufacturing investment goes. A company deciding where to site a new fill-finish or cell therapy facility in Europe increasingly has to weigh local QP availability alongside the usual factors like labor costs and logistics, since a facility that cannot staff enough QPs cannot certify enough batches to run at capacity, regardless of how well the production line itself performs. Some larger organizations have responded by building internal QP development programs, identifying quality scientists early in their careers and structuring their rotations specifically to accumulate the kind of practical experience the directive requires, rather than waiting to recruit an already-qualified QP from a thin external market.
How QP Work Differs From US-Style Quality Roles
There is no direct equivalent to the QP role in US pharmaceutical regulation. FDA's quality system regulations place batch release authority with the manufacturer's quality unit as an organizational function, and while a specific person typically signs the release, that authority is not tied to an individually licensed, government-registered designation the way it is in the EU. A US-based Vice President of Quality or Quality Director carries real organizational accountability, but not the same personal, legally defined liability that attaches to a European QP's signature. For professionals moving between US and EU quality organizations, this is one of the more consequential structural differences to understand, since a senior US quality title does not translate into QP eligibility without meeting the EU's separate qualification and registration requirements.
What Draws People Toward QP Work
Despite the pressure, QP work attracts a particular kind of quality professional precisely because of the authority it carries. People who move toward it tend to already be strong technical reviewers, comfortable reading a batch record critically rather than skimming it for completeness, and drawn to a role where their judgment is the final word rather than one input into a group decision. The path there is deliberately slow, which filters out people chasing the title without the underlying appetite for the responsibility; most QPs spend years in analytical, manufacturing or quality assurance roles building the specific kind of hands-on familiarity with GMP operations that the directive's experience requirement is designed to produce, rather than arriving at QP work as an early-career ambition. For those who do reach it, the role offers something increasingly rare in large organizations: a single, clearly defined point of accountability where the professional's own name, not a department, stands behind the decision.
Conclusion
The Qualified Person role is a reminder that not every accountability structure in pharmaceutical manufacturing has converged toward committee-based decision making. It remains, by design, a single person's signature and a single person's legal responsibility, built on a specific combination of scientific training, years of practical GMP experience, and formal recognition by a national authority. For quality and manufacturing professionals building a career toward it, that narrow path is also what keeps the role in short supply, and in demand, across European pharmaceutical and biotechnology manufacturing, and it is likely to stay that way as biologics and advanced therapy manufacturing capacity keeps expanding faster than the pipeline of people eligible to certify what comes off those lines.

Regulatory & Quality. REWIRED.
New roles. Real pay. Your next move.
- Hand-picked roles, every week.
- The newest company pages.
- One article worth your time.
Free. Thursday mornings. One-click unsubscribe.
Find your next regulatory or quality role
Every role on Regulatory Jobs is in regulatory, quality or clinical, in pharma, biotech or medical devices. Set an alert and the next one reaches you the day it posts.





